Artivion (AORT) Change in Accured Expenses (2010 - 2026)
Artivion (AORT) reported Change in Accured Expenses of -$8.7 million for Q1 2026, up 45.78% on a YoY basis from -$6.0 million in Q1 2025, and down 192.83% quarter-over-quarter from $9.4 million in Q4 2025.
Artivion (AORT) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Artivion has reported Change in Accured Expenses for 17 years, with the latest figure at -$8.7 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses rose 45.78% year-over-year to -$8.7 million; the trailing twelve-month figure through Mar 2026 stood at $9.5 million (up 258.38% YoY), and the FY2025 full-year result was $2.2 million, down 77.02% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at -$8.7 million, down from $9.4 million in the prior quarter.
- The five-year high for Change in Accured Expenses was $14.7 million in Q4 2024, with the low at -$16.1 million in Q1 2025.
- Historically, Change in Accured Expenses has averaged $487058.8 across 5 years, with a median of $794000.0 in 2024.
- Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 308.81% — and 2023, when it soared 436.02%.
- Artivion's Change in Accured Expenses stood at $2.9 million in 2022, then surged by 40.26% to $4.1 million in 2023, then soared by 260.89% to $14.7 million in 2024, then slumped by 36.37% to $9.4 million in 2025, then plunged by 192.83% to -$8.7 million in 2026.
- The last three Change in Accured Expenses figures came in at -$8.7 million (Q1 2026), $9.4 million (Q4 2025), and -$967000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Artivion | 1.02 Bn | 961.48 Mn | 75.45 Mn | -8.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.70 Mn |
| Mar 31, 2026 | -8.70 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Dec 31, 2025 | 9.38 Mn |
| Sep 30, 2025 | -967,000.00 |
| Sep 30, 2025 | -967,000.00 |
| Jun 30, 2025 | 9.83 Mn |
| Jun 30, 2025 | 9.83 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Mar 31, 2025 | -16.05 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Dec 31, 2024 | 14.74 Mn |
| Sep 30, 2024 | 794,000.00 |
| Sep 30, 2024 | 794,000.00 |
| Jun 30, 2024 | 3.19 Mn |
| Jun 30, 2024 | 3.19 Mn |
| Mar 31, 2024 | -9.22 Mn |
| Mar 31, 2024 | -9.22 Mn |
| Dec 31, 2023 | 4.08 Mn |
| Dec 31, 2023 | 4.08 Mn |